SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Pelthos Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update

Zelsuvmi® net product revenue grew 114% to $15.2 million during the third quarter of 2026 from $7.1

PTHS

Related stories